BOLT vs MKC · rev $7.7M vs P/E 8.4, $13.56B cap
Bolt Biotherapeutics (BOLT) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
MKC does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the BOLT and MKC stock pages for the full models.
Not investment advice.